TABLE A7.
Visit | Category | Statistic | Osimertinib, nM | AZ5104, nM | ||||
---|---|---|---|---|---|---|---|---|
T790M– | T790M+ | All | T790M– | T790M+ | All | |||
C3D1 | Free plasma concentration, nM | No. Geometric mean (CV%) Range |
48 19.07 (84.46) 1.00-74.20 |
1 29.20 |
49 19.24 (83.70) 1.00-74.20 |
48 3.03 (81.91) 0.22-20.22 |
1 42.30 |
49 3.04 (80.84) 0.22-20.22 |
CSF concentration, nM | No. Geometric mean (CV%) Range |
36 4.55 (105.37) 0.46-47.70 |
1 0.41 |
37 4.58 (103.49) 0.46-47.70 |
36 0.30 (97.81) 0.08-5.98 |
1 0.41 |
37 0.30 (96.19) 0.08-5.98 |
|
Free plasma metabolite-to-parent ratio | No. Ratio (CV%) Range |
NA | NA | NA | 48 0.16 (64.87) 0.09-0.55 |
1 0.11 |
49 0.16 (34.84) 0.09-0.55 |
|
CSF metabolite-to-parent ratio | No. Ratio (CV%) Range |
NA | NA | NA | 36 0.07 (52.85) 0.037-0.290 |
1 0.07 |
37 0.066 (52.02) 0.037-0.290 |
|
CSF-to-free plasma ratio | No. Ratio (CV%) Range |
36 22.25 (63.34) 3.80-64.29 |
1 20.44 |
37 22.20 (62.47) 3.80-64.29 |
36 10.21 (53.05) 3.29-29.57 |
1 12.21 |
37 10.25 (52.32) 3.29-29.57 |
|
C6D1 | Free plasma concentration, nM | No. Geometric mean (CV%) Range |
41 21.87 (59.73) 3.91-69.96 |
NA | 41 21.87 (59.73) 3.91-69.96 |
41 3.34 (71.11) 0.64-19.51 |
NA | 41 3.34 (71.11) 0.64-19.51 |
CSF concentration, nM | No. Geometric mean (CV%) Range |
30 4.81 (88.16) 0.84-21.70 |
1 2.74 |
31 4.72 (87.25) 0.84-21.70 |
30 0.29 (72.75) 0.11-1.35 |
1 0.22 |
31 0.29 (71.58) 0.11-1.35 |
|
Free plasma metabolite-to-parent ratio | No. Ratio (CV%) Range |
NA | NA | NA | 41 0.15 (24.51) 0.09-0.30 |
0 | 41 0.15 (24.51) 0.09-0.30 |
|
CSF metabolite-to-parent ratio | No. Ratio (CV%) Range |
NA | NA | NA | 30 0.06 (48.09) 0.03-0.19 |
1 0.078 |
31 0.06 (47.46) 0.03-0.19 |
|
CSF-to-free plasma ratio | No. Ratio (CV%) Range |
30 22.12 (80.14) 4.73-82.29 |
NA | 30 22.12 (80.14) 4.73-82.29 |
30 9.33 (59.57) 3.78-29.41 |
NA | 30 9.33 (59.57) 3.78-29.41 |
Abbreviations: CSF, cerebrospinal fluid; CV, Coefficient of Variation; NA, not available.